Fahima Akter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fahima Akter has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Anahita Sadat
Department of Internal Medicine, Dhaka Medical College and Hospital, Dhaka, BGD
1 shared publication - Anid Hassan
Department of Internal Medicine, Holy Family Red Crescent Medical College Hospital, Dhaka, BGD
1 shared publication Cheng Chung
Pulmonary and Critical Care Medicine, Indiana University Health Arnett Hospital, Lafayette, USA
1 shared publication- Fariah Asha Haque
Department of Gastroenterology and Hepatology, University of Louisville, Louisville, KY 40202, USA
1 shared publication Hannah Bozell
Pediatrics, Albany Medical Center, Albany, USA
1 shared publication- Ishra Jalal
Department of Internal Medicine, Khulna Medical College and Hospital, Khulna, BGD
1 shared publication
Latest Publications
- Open Access
- 3 October 2024
- Published by Springer Nature in Cureus
- Vol. 16 (10) , e70794
Linezolid-Induced Lactic Acidosis Presenting As Acute Cholecystitis: A Case Report and Systematic Review
Linezolid has gained increased use for the treatment of infections caused by multidrug-resistant Gram-positive bacteria in recent years. It can cause rare but potentially life-threatening lactic acidosis. Here, we presented a case report of linezolid-induced lactic acidosis (LILA), along with a systematic review of current literature.
- 3 October 2024
- Published by Springer Nature in Cureus
- Vol. 16 (10) , e70794
Open AccessLinezolid-Induced Lactic Acidosis Presenting As Acute Cholecystitis: A Case Report and Systematic Review
Linezolid has gained increased use for the treatment of infections caused by multidrug-resistant Gram-positive bacteria in recent years. It can cause rare but potentially life-threatening lactic acidosis. Here, we presented a case report of linezolid-induced lactic acidosis (LILA), along with a systematic review of current literature.
- Open Access
- 17 September 2022
- Published by Springer Nature in Cureus
- Vol. 14 (9) , e29297
Exacerbation of Pre-existing Neurological Symptoms With COVID-19 in Patients With Chronic Neurological Diseases: An Updated Systematic Review
The neurotropism of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can potentially explain the worsening of symptoms in patients with a history of neurological conditions such as stroke, Parkinson's disease, Alzheimer's, and epilepsy. Several studies have reported that these pre-existing conditions may worsen with a higher frequency of flare-ups, thus resulting in a more significant risk of patient mortality. In this review, we sought to provide an overview of the relationship between pre-existing neurological disorders and COVID-19, focusing on whether the initial infection directly influenced the severity of symptoms. We systematically searched the electronic database PubMed (MEDLINE) and used specific keywords related to our aims from January 2020 to July 2022. All articles published on COVID-19 with keywords pertaining to pre-existing neurological diseases were retrieved and subsequently analyzed. After independent review, the data from 107 articles were selected and evaluated. After analyzing the data from selected articles reviewing the effect of COVID-19 on neurological conditions, we have documented the relationship between said pre-existing neurological diseases, showing an increased risk of hospitalization, admission length, worsening of symptoms, and even mortality in COVID-19 patients.
- 17 September 2022
- Published by Springer Nature in Cureus
- Vol. 14 (9) , e29297
Open AccessExacerbation of Pre-existing Neurological Symptoms With COVID-19 in Patients With Chronic Neurological Diseases: An Updated Systematic Review
The neurotropism of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can potentially explain the worsening of symptoms in patients with a history of neurological conditions such as stroke, Parkinson's disease, Alzheimer's, and epilepsy. Several studies have reported that these pre-existing conditions may worsen with a higher frequency of flare-ups, thus resulting in a more significant risk of patient mortality. In this review, we sought to provide an overview of the relationship between pre-existing neurological disorders and COVID-19, focusing on whether the initial infection directly influenced the severity of symptoms. We systematically searched the electronic database PubMed (MEDLINE) and used specific keywords related to our aims from January 2020 to July 2022. All articles published on COVID-19 with keywords pertaining to pre-existing neurological diseases were retrieved and subsequently analyzed. After independent review, the data from 107 articles were selected and evaluated. After analyzing the data from selected articles reviewing the effect of COVID-19 on neurological conditions, we have documented the relationship between said pre-existing neurological diseases, showing an increased risk of hospitalization, admission length, worsening of symptoms, and even mortality in COVID-19 patients.